Century Therapeutics (IPSC) Other Non-Current Assets (2020 - 2026)

Century Therapeutics (IPSC) has 7 years of Other Non-Current Assets data on file, last reported at $2.7 million in Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 2.38% year-over-year to $2.7 million in Q1 2026; TTM through Mar 2026 was $2.7 million, a 2.38% decrease from a year earlier, with the FY2025 full-year figure at $3.2 million, up 13.92% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $2.7 million, down from $3.2 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for IPSC reached as high as $3.2 million in Q3 2025 and fell as low as $563000.0 in Q3 2023.
• Historically, Other Non-Current Assets has averaged $2.1 million across 5 years, with a median of $2.0 million in 2022.
• Across the five-year window, Other Non-Current Assets tumbled 55.95% in 2023 and soared 459.12% in 2025, its largest moves.
• Year by year, Other Non-Current Assets stood at $1.3 million in 2022, then jumped by 57.06% to $2.0 million in 2023, then soared by 40.07% to $2.8 million in 2024, then grew by 13.92% to $3.2 million in 2025, then retreated by 14.22% to $2.7 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $2.7 million in Q1 2026, $3.2 million in Q4 2025, and $3.2 million in Q3 2025.